文献速递其他结缔组织病

系统性硬化症中人类巨噬细胞的促纤维化激活

Profibrotic Activation of Human Macrophages in Systemic Sclerosis.
PubMed 文献 · Arthritis Rheumatol · 2020-05-31

本研究纳入24例系统性硬化症(SSc)患者与12例年龄性别匹配的健康对照,用自体或异体血浆诱导单核细胞分化为巨噬细胞,并与成纤维细胞共培养。结果显示SSc巨噬细胞处于促纤维化激活状态,且健康供者单核细胞在SSc血浆中可分化为具SSc巨噬细胞免疫表型的细胞。

要点

  • SSc巨噬细胞基础状态下即表达活化表面标志并释放CCL2、IL-6和TGF-β。
  • SSc血浆可使健康供者单核细胞获得SSc巨噬细胞的免疫表型。
  • SSc巨噬细胞与SSc成纤维细胞共培养可诱导成纤维细胞活化。

核心结论

  • SSc巨噬细胞的激活谱为促纤维化,其激活可能源于局部微环境中的可溶性因子,提示巨噬细胞可能是SSc纤维化的驱动因素,靶向这些细胞可能对改善病情有益。

研究设计与样本

  • 获取24例SSc患者与12例年龄性别匹配健康对照的血浆和外周血单个核细胞(PBMC)。
  • 单核细胞与自体或异体血浆共培养分化为巨噬细胞;用Transwell板进行巨噬细胞与成纤维细胞的交互激活研究。

主要发现

  • SSc巨噬细胞相关基因表达特征在独立队列的SSc皮肤中富集并与皮肤纤维化相关。
  • SSc巨噬细胞表达活化相关表面标志,基础条件下释放CCL2、IL-6和转化生长因子β(n=8)(P < 0.05)。
  • 健康供者单核细胞在SSc患者血浆中分化后获得SSc巨噬细胞的免疫表型(n=13)(P < 0.05)。
  • Transwell实验显示SSc巨噬细胞与SSc成纤维细胞共培养可诱导成纤维细胞活化(n=3)(P < 0.05)。

临床怎么用

  • 提示巨噬细胞可能是SSc纤维化的驱动细胞,靶向巨噬细胞活化或为SSc治疗的潜在方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Genome-wide gene expression studies implicate macrophages as mediators of fibrosis in systemic sclerosis (SSc), but little is known about how these cells contribute to fibrotic activation in SSc. We undertook this study to characterize the activation profile of SSc monocyte-derived macrophages and assessed their interaction with SSc fibroblasts. METHODS: Plasma and peripheral blood mononuclear cells (PBMCs) were obtained from whole blood from SSc patients (n = 24) and age- and sex-matched healthy controls (n = 12). Monocytes were cultured with autologous or allogeneic plasma to differentiate cells into macrophages. For reciprocal activation studies, macrophages were cocultured with fibroblasts using Transwell plates. RESULTS: The gene expression signature associated with blood-derived human SSc macrophages was enriched in SSc skin in an independent cohort and correlated with skin fibrosis. SSc macrophages expressed surface markers associated with activation and released CCL2, interleukin-6, and transforming growth factor β under basal conditions (n = 8) (P < 0.05). Differentiation of healthy donor monocytes in plasma from SSc patients conferred the immunophenotype of SSc macrophages (n = 13) (P < 0.05). Transwell experiments demonstrated that coculture of SSc macrophages with SSc fibroblasts induced fibroblast activation (n = 3) (P < 0.05). CONCLUSION: These data demonstrate that the activation profile of SSc macrophages is profibrotic. SSc macrophages are activated under basal conditions and release mediators and express surface markers associated with both alternative and inflammatory macrophage activation. These findings also suggest that activation of SSc macrophages arises from soluble factors in local microenvironments. These studies implicate macrophages as likely drivers of fibrosis in SSc and suggest that therapeutic targeting of these cells may be beneficial in ameliorating disease in SSc patients.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Bhandari R, Ball MS, Martyanov V, et al. Profibrotic Activation of Human Macrophages in Systemic Sclerosis. Arthritis Rheumatol. 2020. PMID: 32134204. doi:10.1002/art.41243

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。